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Carcinosarcomas  are  rare  tumors  that  most  com-
monly develop in the female genital tract, particularly in 
the uterus1,2. Characteristic histopathological findings are 
coexistence of both epithelial and nonepithelial malignant 
components1,2. Development of carcinosarcomas has been 
demonstrated in various human organs, including the uter-
us1,2, ovary3,4, breast5, lung6,7 and gastrointestinal tract8–11. 
Although  spontaneous  carcinosarcomas  in  the  uterus  of 
LEWIS rats12 and mammary gland of SD rats13 have been 
documented, no reports about this tumor type in Wistar 
Hannover GALAS rats have been published. In this article, 
we report a case of carcinosarcoma of the uterus in a female 
Wistar Hannover GALAS rat at 2 years of age.
In  this  study,  Wistar  Hannover  GALAS  [BrlHan: 
WIST@Jcl (GALAS)] rats (CLEA Japan, Tokyo, Japan) 
were randomly allocated to three groups, each consisting 
of 50 males and 50 females, and groups of rats of each sex 
were fed a tocotrienol-containing basal diet (CE-2; CLEA 
Japan, Tokyo, Japan) and tap water ad libitum for 104 weeks 
beginning at 6 weeks of age. The tocotrienol dose levels in 
the diet in the high-dose group were 2.0% during weeks 
1–50 and 1.0% for the remainder of the study. The tocotri-
enol (Eisai, Tokyo, Japan) given in this study was composed 
of a-tocotrienol (21.4%), b-tocotrienol (3.5%), g-tocotrienol 
(36.5%),  d-tocotrienol  (8.6%),  a-tocopherol  (20.5%),  b-
tocopherol  (0.7%),  g-tocopherol  (1.0%)  and  d-tocopherol 
(0.5%). The animals were housed in a clear polycarbonate 
cage with sterilized white wood chips (Sankyo Labo Ser-
vice Corporation, Tokyo, Japan) for bedding in a standard 
air-conditioned room (24 ± 1 °C, 55 ± 5% relative humidity, 
12 h light/dark cycles). At the end of experiment, we found 
one animal with a large mass (1.0 × 0.9 × 0.8 cm) in the left 
horn of the uterus within the 47 animals in the high-dose 
group. The mass was dissected with the uterus and fixed 
in 10% neutral buffered formalin. Macroscopically, nodules 
were also observed in the pituitary gland and pectoral sub-
cutis. After fixation, the tissues were routinely processed, 
i.e., embedded in paraffin, sectioned at 4 mm and stained 
with hematoxylin and eosin (HE). Additionally, toluidine 
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blue  stain  and  immunohistochemical  staining  for  rabbit 
anti-cow S-100 protein (DAKO, Glostrup, Denmark), anti-
human cytokeratin (clones AE1/AE3; DAKO), anti-porcine 
vimentin  (clone  V9;  DAKO)  and  anti-human  E-cadherin 
(clone 36; BD Biosciences, Franklin Lakes, NJ, USA) were 
performed using serial sections. The animal experimental 
protocol was reviewed and approved by the Animal Care 
and Use Committee of the National Institute of Health Sci-
ences, Japan.
Histopathologically, a neoplastic nodule appeared to 
protrude into the lumen of the uterus (Fig 1a, b). Invasion 
of tumor cells from the myometrium into the serosa were 
observed (Fig 1c). Two distinct types of tumor cells were 
observed in this nodule (Fig 1d). The first component was 
characterized by a proliferative pattern of tumor cells in ir-
regular gland-like, solid sheets or nests. This type of tumor 
cell had large round or elliptical nuclei with a few apparent 
nucleoli and scant or moderate and eosinophilic or basophil-
ic cytoplasm (Fig 2a-c), indicating endometrial carcinoma. 
Severe necrosis, mineralization and multiple mitoses were 
observed. Tumor cells with abundant collagen invaded from 
the myometrium into the serosa and were either single cells 
or clusters of a few cells (Fig 2d). Immunohistochemically, 
the tumor cells showing a glandular pattern were strongly 
positive  for  cytokeratin  and  E-cadherin  and  negative  for 
vimentin,  while  those  with  a  solid  pattern  were  weakly 
positive for cytokeratin, partially positive for E-cadherin 
and mostly positive for vimentin (Fig 2e, f). The second 
component, which was characterized by a proliferation of 
polymorphic  tumor  cells  with  a  pale  basophilic  matrix, 
was focally observed within the carcinomatous component. 
This type of tumor cell had round or oval nuclei with severe 
atypia and an appreciable amount of clear to eosinophilic 
cytoplasm (Fig 3a, b). The pale basophilic matrix exhibited 
metachromasia by toluidine blue staining, indicating carti-
lage matrix. These tumor cells were negative for E-cadherin, 
weakly positive for cytokeratin and intensely positive for vi-
mentin and S-100 protein (Fig 3c, d). Thus, this sarcomatous 
component was diagnosed as chondrosarcoma. Transitions 
between carcinomatous and sarcomatous components were 
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Fig. 1.  Uterine carcinosarcoma. (a) Overall picture of the uterine carcinosarcoma. HE stain. Bar=2 mm. (b) High magnifica-
tion of the region enclosed in the large square in a. The upper half is an existing uterine area. The arrowheads indicate 
existing endometrium and uterine glands. The lower half is the tumor area. HE stain. Bar=400 mm. (c) High magnifi-
cation of the region enclosed in the small square in a. Invasion of tumor cells is observed from the myometrium into 
the serosa. The arrows indicate the myometrium. HE stain. Bar=200 mm. (d) Epithelial and nonepithelial malignant 
components are observed in a nodule. HE stain. Bar=200 mm.  Takami, Ogawa, Umemura et al.
observed (Fig 1a, d). Although myometrial and vascular in-
vasion and serosal involvement were observed, no metas-
tasis was seen. Primary carcinomas were also seen in the 
pituitary gland and mammary gland of this animal. Macro-
scopically and microscopically, carcinosarcomas were not 
observed in other animals including the tocotrienol-treated 
and control animals.
Based  on  the  present  histopathological  and  immu-
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Fig. 2.  Histopathological and immunohistochemical findings of carcinomatous elements in the uterine carcinosarcoma. (a) Irregular glandular 
structures and solid sheet structures of tumor cells. HE stain. Bar=200 mm. (b) High magnification of glandular area in a. Tumor cells 
have large round or elliptical nuclei and moderate eosinophilic cytoplasm. HE stain. Bar=50 mm. (c) High magnification of the solid sheet 
area in a. Tumor cells have large round or oval nuclei and scant basophilic cytoplasm. Mitotic figures are observed (arrowhead). HE stain. 
Bar=50 mm. (d) Invasion of tumor cells with collagen is observed from the myometrium into the serosa. Many small glandular structures 
are seen within the tumor cells. The arrow indicates the myometrium. HE stain. Bar=200 mm. (e) Immunoreactivity for cytokeratin. 
Glandular tumor cells are positive, while solid sheet tumor cells are weakly positive. Bar=100 mm. (f) Immunoreactivity for vimentin. 
Glandular tumor cells are negative, while many of the tumor cells in the solid sheet area are positive (arrowhead). Bar=100 mm.66 Uterine Carcinosarcoma in a Wistar Hannover GALAS Rat
nohistochemical findings, this tumor was diagnosed as a 
uterine  carcinosarcoma.  The  conclusive  histopathological 
findings supporting this diagnosis were the mixture of car-
cinomatous and sarcomatous elements in a single neoplastic 
nodule. This case was further subclassified as the heter-
ologous type because the sarcomatous components showed 
typical chondrosarcoma that had developed from an element 
that did not originally exist. Although carcinosarcomas are 
unusual tumors, they are the most common type of mixed 
epithelial-nonepithelial endometrial tumors1. The progno-
sis of carcinosarcoma is generally poor due to recurrence, 
lymph node metastasis and myometrial and lymph-vascular 
space invasion14,15. Although metastasis to pelvic or periaor-
tic lymph nodes has been reported1,15, metastasis of tumor 
cells was not observed in the mesenteric lymph nodes or 
other organs such as the lung, liver and spleen in the present 
case. Immunohistochemical staining for cytokeratin, a gen-
eral epithelial marker, and vimentin, a typical mesenchymal 
marker, have suggested distinct carcinomatous and sarco-
matous  populations  in  carcinosarcomas8,16,17.  The  present 
immunohistochemical findings were consistent with those 
of the previous reports16,17. Epithelial markers are frequently 
expressed  by  sarcomatous-appearing  cells,  and  epithelial 
and mesenchymal markers are coexpressed in many tumor 
cells  in  carcinosarcomas16,17.  Carcinosarcomas  have  been 
suggested to result from neoplastic transformation of cells 
with a capacity for both epithelial and mesenchymal dif-
ferentiation. The histogenesis of carcinosarcomas has been 
hypothesized to involve a collision tumor, combination/con-
version tumor or other compositional tumor16,18–21. The pres-
ence of many carcinosarcomas has been reported to repre-
sent a combination tumor20,21. Although we did not perform 
a stem cell analysis, the present case may be considered to 
be a combination tumor based on the results of immunohis-
tochemistry and the evidence of mixed and/or transitional 
pattern of carcinomatous and sarcomatous components.
Several nomenclature systems are used to describe this 
type of neoplastic lesion. According to the WHO classifica-
tion22, malignant mesodermal mixed tumor is synonymous 
with  carcinosarcoma,  but  tumors  with  heterologous  and 
Fig. 3.  Histopathological and immunohistochemical findings of sarcomatous elements in the uterine carcinosarcoma. (a) Pro-
liferation of tumor cells with a basophilic matrix. HE stain. Bar=100 mm. (b) High magnification of a. Tumor cells have 
round or oval nuclei and an appreciable amount of eosinophilic cytoplasm. HE stain. Bar=50 mm. (c) Immunoreactiv-
ity for cytokeratin. Tumor cells of epithelial origin are positive, while those of sarcomatous components are weakly 
positive. Bar=100 mm. (d) Immunoreactivity for vimentin. Tumor cells of epithelial origin are negative, while those of 
sarcomatous components are intensely positive. Bar=100 mm.67   Takami, Ogawa, Umemura et al.
homologous sarcomatous components are sometimes diag-
nosed as malignant mesodermal mixed tumor and carcino-
sarcoma, respectively.
The tumor in the present case was detected in only a 
single rat within a group of similarly treated animals. There-
fore, this tumor could be incidental and may not be related 
to the treatment. This is the first report of uterine carcino-
sarcoma in a Wistar Hannover GALAS rat.
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